|
|
Volumn , Issue , 2009, Pages 610-618
|
|
Allogeneic stem cell transplantation in follicular lymphoma: recent progress and controversy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
IMMUNOSUPPRESSIVE AGENT;
MYELOABLATIVE AGENT;
ADULT;
ALLOTRANSPLANTATION;
CLINICAL TRIAL;
DRUG RESISTANCE;
FOLLICULAR LYMPHOMA;
GRAFT VERSUS HOST REACTION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LIVING DONOR;
LYMPHOCYTE DEPLETION;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
PROGNOSIS;
RECURRENT DISEASE;
RETROSPECTIVE STUDY;
REVIEW;
SURVIVAL;
WHOLE BODY RADIATION;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS AS TOPIC;
COMBINED MODALITY THERAPY;
DRUG RESISTANCE, NEOPLASM;
GRAFT VS HOST DISEASE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIVING DONORS;
LYMPHOCYTE DEPLETION;
LYMPHOMA, FOLLICULAR;
MIDDLE AGED;
MYELOABLATIVE AGONISTS;
PROGNOSIS;
RECURRENCE;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION, HOMOLOGOUS;
WHOLE-BODY IRRADIATION;
YOUNG ADULT;
|
|
EID: 77949467438
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation-2009.1.610 Document Type: Review |
|
Times cited : (18)
|
|
References (40)
|
